HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pieter Jan van Doormaal Selected Research

Pieter Jan van Doormaal Research Topics

Disease

8Ischemic Stroke
05/2023 - 10/2020
8Stroke (Strokes)
02/2023 - 11/2021
2Infarction (Infarctions)
02/2023 - 10/2022
1Neurologic Manifestations (Neurological Manifestations)
02/2023
1Pneumonia (Pneumonitis)
07/2022
1Cerebral Infarction
01/2021
1Hyperlipidemias (Hyperlipidemia)
01/2021
1Neoplasms (Cancer)
03/2020
1Hypertension (High Blood Pressure)
09/2017
1Asphyxia (Suffocation)
04/2012

Drug/Important Bio-Agent (IBA)

2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2022 - 10/2022
2Heparin (Liquaemin)FDA LinkGeneric
12/2022 - 10/2022
1Biomarkers (Surrogate Marker)IBA
02/2023
1cyclo(Arg-Pro) (CI 4)IBA
07/2022
1Tissue Plasminogen Activator (Alteplase)FDA Link
11/2021
1Lactic Acid (Lactate)FDA LinkGeneric
04/2012
1Choline (Choline Chloride)IBA
04/2012
1CreatineIBA
04/2012
1N-acetylaspartate (N-acetyl aspartate)IBA
04/2012

Therapy/Procedure

5Thrombectomy
05/2023 - 01/2021
2Therapeutics
01/2023 - 01/2021
2Stents
01/2023 - 01/2021
2Time-to-Treatment
01/2022 - 10/2020
1Punctures
01/2022
1Microspheres (Microsphere)
03/2020
1Denervation
09/2017